X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (143171) 143171
Newsletter (27905) 27905
Newspaper Article (11585) 11585
Magazine Article (1574) 1574
Book Chapter (798) 798
Dissertation (508) 508
Transcript (472) 472
Book / eBook (206) 206
Web Resource (151) 151
Conference Proceeding (125) 125
Government Document (92) 92
Trade Publication Article (77) 77
Publication (73) 73
Streaming Video (58) 58
Book Review (38) 38
Report (29) 29
Paper (25) 25
Reference (25) 25
Journal / eJournal (15) 15
Video Recording (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antiviral agents (89953) 89953
humans (87278) 87278
antiviral agents - therapeutic use (39460) 39460
female (34355) 34355
male (33612) 33612
animals (28856) 28856
hiv (26662) 26662
health aspects (26057) 26057
adult (24964) 24964
research (24367) 24367
antiviral agents - pharmacology (23807) 23807
middle aged (21503) 21503
virology (20718) 20718
aids (18788) 18788
infection (17579) 17579
drug therapy (17193) 17193
viruses (17089) 17089
infectious diseases (17079) 17079
pharmacology & pharmacy (15242) 15242
analysis (14945) 14945
virus diseases (14665) 14665
immunology (14645) 14645
treatment outcome (12958) 12958
care and treatment (12700) 12700
microbiology (12576) 12576
anti-hiv agents (12534) 12534
hepatitis c virus (11802) 11802
highly active antiretroviral therapy (11625) 11625
antiviral activity (11486) 11486
hepatitis c (11454) 11454
medical research (11410) 11410
infections (10909) 10909
antiviral agents - administration & dosage (10812) 10812
interferon (10760) 10760
gastroenterology & hepatology (10696) 10696
mice (10623) 10623
hiv infections - drug therapy (10520) 10520
hepatitis c, chronic - drug therapy (10309) 10309
hiv infection (10126) 10126
drug therapy, combination (9985) 9985
medicine, experimental (9957) 9957
aged (9701) 9701
therapy (9445) 9445
cell line (9131) 9131
biochemistry & molecular biology (8806) 8806
risk factors (8312) 8312
human immunodeficiency virus--hiv (8292) 8292
virus replication - drug effects (7765) 7765
influenza (7527) 7527
hepatitis (7429) 7429
replication (7402) 7402
interferon-alpha - therapeutic use (7401) 7401
antiviral agents - adverse effects (7246) 7246
viral load (7217) 7217
adolescent (7127) 7127
antiviral agents - chemistry (6966) 6966
research article (6958) 6958
hepatitis b (6920) 6920
rna (6591) 6591
ribavirin (6572) 6572
drugs (6476) 6476
genotype (6425) 6425
prevention (6391) 6391
ribavirin - therapeutic use (6383) 6383
proteins (6271) 6271
hiv patients (6186) 6186
chemistry, medicinal (6171) 6171
pharmaceutical industry (6008) 6008
antivirals (5988) 5988
medicine (5930) 5930
hepacivirus - genetics (5911) 5911
antiretroviral therapy (5844) 5844
universities and colleges (5803) 5803
virus (5774) 5774
multidisciplinary sciences (5594) 5594
young adult (5550) 5550
time factors (5527) 5527
hepatitis c - drug therapy (5525) 5525
dosage and administration (5407) 5407
antiviral therapy (5245) 5245
retrospective studies (5238) 5238
in-vitro (5193) 5193
drug resistance (5169) 5169
mutation (5166) 5166
medicine, general & internal (5143) 5143
recombinant proteins (5078) 5078
child (5037) 5037
hiv-1 - drug effects (4984) 4984
liver (4966) 4966
human-immunodeficiency-virus (4914) 4914
antiviral (4879) 4879
mortality (4794) 4794
transplantation (4766) 4766
biological response modifiers (4758) 4758
hepatitis b, chronic - drug therapy (4728) 4728
hepacivirus - drug effects (4692) 4692
usage (4669) 4669
disease (4667) 4667
genetic aspects (4645) 4645
hepatitis b virus (4529) 4529
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (140) 140
Gerstein Science - Stacks (117) 117
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
UofT at Mississauga - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
UofT at Scarborough - Stacks (6) 6
Gerstein Science - Periodical Stacks (5) 5
Media Commons - Audio Visual (3) 3
Gerstein Science - Bindery (2) 2
New College (Ivey) - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Processing (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Government Pubs (1) 1
St. Michael's Hospital - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (178285) 178285
French (1834) 1834
Russian (1535) 1535
Chinese (1529) 1529
Japanese (1500) 1500
German (1351) 1351
Spanish (651) 651
Korean (438) 438
Polish (331) 331
Portuguese (257) 257
Italian (177) 177
Hungarian (166) 166
Czech (92) 92
Ukrainian (85) 85
Danish (81) 81
Dutch (77) 77
Swedish (70) 70
Croatian (44) 44
Bulgarian (37) 37
Romanian (37) 37
Norwegian (36) 36
Finnish (34) 34
Turkish (34) 34
Serbian (30) 30
Hebrew (27) 27
Persian (12) 12
Slovak (11) 11
Arabic (10) 10
Lithuanian (7) 7
Bosnian (4) 4
Icelandic (4) 4
Breton (3) 3
Afrikaans (1) 1
Albanian (1) 1
Belarusian (1) 1
Catalan (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antiviral agents bulletin, ISSN 0897-9871, 1988
Journal
Antiviral chemistry & chemotherapy, ISSN 0956-3202, 1990
Journal
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 1972
Journal
Advances in antiviral drug design, ISSN 1075-8593, 1993
Journal
1990, 1, ISBN 0849365414, 200
This timely publication describes the botanical sources and chemical features of antiviral compounds. It covers their mechanisms of action and evaluates their... 
Plant antiviral agents | Plantes | Antiviraux | Botany
Book
Nature (London), ISSN 1476-4687, 2014, Volume 508, Issue 7496, pp. 402 - 405
Filoviruses are emerging pathogens and causative agents of viral haemorrhagic fever. Case fatality rates of filovirus disease outbreaks are among the highest... 
NONHUMAN-PRIMATES | CHALLENGE | REPLICATION | HEMORRHAGIC-FEVER | MARBURG-VIRUS | MULTIDISCIPLINARY SCIENCES | POSTEXPOSURE PROTECTION | MOUSE MODEL | ANTIVIRAL ACTIVITY | EBOLA-VIRUS INFECTION | SMALL-MOLECULE INHIBITOR | Antiviral Agents - pharmacokinetics | DNA-Directed RNA Polymerases - antagonists & inhibitors | Hemorrhagic Fever, Ebola - prevention & control | Marburg Virus Disease - virology | Purine Nucleosides - pharmacology | Humans | Purine Nucleosides - pharmacokinetics | Ebolavirus - drug effects | Time Factors | Antiviral Agents - chemistry | Hemorrhagic Fever, Ebola - virology | Marburg Virus Disease - prevention & control | Disease Models, Animal | Antiviral Agents - pharmacology | Administration, Oral | Purine Nucleosides - chemistry | Filoviridae - drug effects | Injections, Intramuscular | Antiviral Agents - administration & dosage | Purine Nucleosides - administration & dosage | RNA - biosynthesis | Animals | Filoviridae Infections - prevention & control | Adenosine - analogs & derivatives | Filoviridae Infections - virology | Marburgvirus - drug effects | Filoviridae - enzymology | DNA-Directed RNA Polymerases - metabolism | Macaca fascicularis - virology | Prevention | Pharmaceutical research | Antiviral agents | Research | RNA virus infections | Nucleoside analogs | Enzymes | Viruses | Infections | Disease | Laboratory animals | Ebola virus | Pharmaceutics | Marburg virus | Antivirals
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 1/2009, Volume 48, Issue S1, pp. S26 - S27
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2010, Volume 54, Issue 6, pp. 1114 - 1122
Background & Aims BI201335 is a highly specific and potent HCV protease inhibitor. This multiple rising dose trial evaluated antiviral activity and safety in... 
Gastroenterology and Hepatology | Antiviral | Resistant variants | Hepatitis C virus | Pegylated interferon | Ribavirin | PLUS RIBAVIRIN | BILN-2061 | TELAPREVIR | EFFICACY | VX-950 | HEPATITIS-C-VIRUS | IN-VITRO | EARLY ANTIVIRAL ACTIVITY | PEGINTERFERON ALPHA-2A | ATAZANAVIR | GASTROENTEROLOGY & HEPATOLOGY | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Protease Inhibitors - pharmacokinetics | Humans | Middle Aged | Hepacivirus - genetics | Male | Thiazoles - administration & dosage | Recombinant Proteins | Oligopeptides - adverse effects | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Protease Inhibitors - pharmacology | Hepatitis C - blood | Ribavirin - administration & dosage | Protease Inhibitors - administration & dosage | Protease Inhibitors - adverse effects | Adult | Female | Hepacivirus - drug effects | Antiviral Agents - pharmacology | Double-Blind Method | Oligopeptides - pharmacokinetics | Carrier Proteins - antagonists & inhibitors | Viral Nonstructural Proteins - genetics | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Interferon-alpha - administration & dosage | Drug Resistance, Viral - genetics | Hepacivirus - enzymology | Antiviral Agents - adverse effects | Hepatitis C - virology | Oligopeptides - administration & dosage | Thiazoles - pharmacology | Oligopeptides - pharmacology | Viral Load - drug effects | Viral Nonstructural Proteins - antagonists & inhibitors | Medical colleges | Antiviral agents | Care and treatment | Safety and security measures | Hotels and motels | Immunodeficiency | Aspartate | Biological response modifiers | HIV (Viruses) | Anti-HIV agents | Complications and side effects | Protease inhibitors | Proteases | Genetic aspects | Hepatitis C | Viral Nonstructural Proteins | Oligopeptides | Polyethylene Glycols | Interferon-alpha | Protease Inhibitors | Drug Resistance, Viral | Antiviral Agents | Viral Load | Life Sciences | Thiazoles | Hepacivirus | Carrier Proteins | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 10, p. e13687
Journal Article
PloS one, ISSN 1932-6203, 2010, Volume 5, Issue 8, p. e12309
Background: Topical microbicides, used by women to prevent the transmission of HIV and other sexually transmitted infections are urgently required. Dendrimers... 
TYPE-1 REPLICATION | HERPES-SIMPLEX-VIRUS | HIV-INFECTION | MULTIDISCIPLINARY SCIENCES | CANDIDATE TOPICAL MICROBICIDES | VAGINAL MICROBICIDES | SPL7013 GEL | RANDOMIZED CONTROLLED-TRIAL | HUMAN-IMMUNODEFICIENCY-VIRUS | L-LYSINE DENDRIMERS | MACROPHAGE TROPISM | Dendrimers - metabolism | Humans | Molecular Conformation | Structure-Activity Relationship | Antiviral Agents - metabolism | HIV Envelope Protein gp120 - metabolism | Receptors, CCR5 - metabolism | Antiviral Agents - chemistry | Female | HIV Envelope Protein gp120 - chemistry | Dendrimers - pharmacology | Herpesvirus 2, Human - drug effects | Cell Line | HIV-1 - metabolism | Antiviral Agents - pharmacology | HIV-1 - drug effects | Drug Stability | Models, Molecular | Dendrimers - chemical synthesis | Receptors, CXCR4 - metabolism | Animals | Antiviral Agents - chemical synthesis | Dendrimers - chemistry | Mice | Lysine - chemistry | Prevention | Antiviral agents | Dendrimers | Sexually transmitted diseases | Disease transmission | Surface active agents | Lysine | Analysis | HIV (Viruses) | Health aspects | Cell culture | Toxicity | Viruses | Hydrophobicity | Cell fusion | Nanoparticles | Immunology | Microbicides | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Antiviral activity | Biocompatibility | CCR5 protein | Automation | Vagina | Glycoproteins | CXCR4 protein | Virology | Cores | Studies | Naphthalene | Acids | In vivo methods and tests | Circumcision | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
PLoS Pathogens, ISSN 1553-7366, 10/2010, Volume 6, Issue 10, p. e1001163
In a screen for RNA mutagen resistance, we isolated a high fidelity RNA dependent RNA polymerase (RdRp) variant of Coxsackie virus B3 (CVB3). Curiously, this... 
NUCLEOSIDE ANALOGS |